Quant MF's Tandon Targets Power, Pharma, BFSI Amid Market Volatility

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorKavya Nair|Published at:
Quant MF's Tandon Targets Power, Pharma, BFSI Amid Market Volatility
Overview

Quant Mutual Fund's Sandeep Tandon is overweighting the power, pharmaceutical, and BFSI sectors, seeing strong long-term growth potential. Power benefits from data center demand, BFSI shows structural strength, but pharma faces high input costs needing careful stock picks. Tandon is cautious on manufacturing due to rising costs and uncertain demand, aligning with recent economic data.

Sandeep Tandon of Quant Mutual Fund is strategically favoring the power, pharmaceutical, and BFSI sectors, believing they offer strong long-term growth potential despite current market turbulence, which includes geopolitical tensions and foreign institutional investor outflows. This focus contrasts with a cautious outlook on manufacturing, driven by distinct sector dynamics and economic trends.

Power Sector Driven by Data Demand

The power sector is seeing a surge driven by demand from data centers, artificial intelligence, and electric vehicles. This is projected to significantly increase India's peak power demand, requiring an additional 30 GW over the next six years. Electricity consumption for data centers alone could reach 40-45 TWh by 2030. Meeting this demand will heavily test existing power infrastructure, with grid strengthening and transmission readiness identified as key challenges. While thermal power will play a vital role in meeting demand, the sector's ability to rapidly scale capacity is crucial. Power stocks have recently led market recoveries due to these strong demand dynamics.

Pharma Faces Cost Pressures

Tandon views the pharmaceutical sector, especially generics, positively but acknowledges significant risks from rising input costs. Indian drugmakers face sharply higher raw material expenses, with some costs up 200-300% due to global supply chain issues and conflicts. This inflation threatens smaller companies and could lead to industry consolidation or supply disruptions. While domestic and European markets show steady growth, the key U.S. generics market continues to face pricing challenges, though a shift towards more complex products offers some relief.

BFSI Shows Structural Strength

The banking, financial services, and insurance (BFSI) sector remains a focus for Quant Mutual Fund, supported by strong structural growth prospects. The sector is benefiting from robust credit demand across retail, small and medium enterprises, and agriculture. Asset quality is improving, and margins are stabilizing. Digital innovations, including AI for credit risk, digital lending, and regulatory technology (RegTech), are reshaping the industry. Quant Mutual Fund has increased its investments in select private banks and insurance firms, reflecting confidence in their fundamental strength.

Manufacturing Sector Faces Challenges

The cautious stance on manufacturing is due to a recent economic slowdown. India's manufacturing Purchasing Managers' Index (PMI) fell in March 2026, as output growth eased amid concerns over market instability, higher raw material costs for items like chemicals and steel, and weaker export demand. Companies are currently absorbing some cost increases by reducing their profit margins, a trend likely to continue given ongoing geopolitical uncertainties and volatile global trade policies.

Key Risks and Concerns

Despite Tandon's strategic focus, significant risks persist. In pharmaceuticals, severe input cost inflation could threaten the survival of smaller and mid-sized companies, potentially leading to defaults and a less diverse market. For the power sector, inadequate grid and transmission infrastructure could hinder the scaling needed to meet projected demand, risking supply-demand imbalances. The BFSI sector, while fundamentally strong, faces pressure from consistent foreign institutional investor (FII) outflows and a weakening rupee, which can impact market sentiment and asset valuations. Furthermore, the manufacturing slowdown could worsen if global trade protectionism rises or geopolitical disruptions continue, hitting export-led growth and profit margins harder than expected.

Economic Outlook and Sector Prospects

Despite short-term global volatility, India's macroeconomic fundamentals are viewed as strong, with economic growth projected at 7.1% for 2026. The power sector is expected to see continued demand growth, though scaling infrastructure remains a key requirement. Analysts predict steady revenue increases for the pharmaceutical sector, with varied performance across regions. BFSI is anticipated to maintain its growth path, supported by strong credit demand and evolving financial infrastructure. The manufacturing sector faces immediate challenges from cost pressures and demand uncertainty, suggesting a potentially gradual recovery that will depend on global economic stabilization and domestic policy.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.